A Phase 2 Study of XmAb 20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer, Cervical Carcinoma
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Female
  • Other Inclusion Criteria:
    1. Cancer must have progressed after treatment with all approved and medically appropriate therapies or have no appropriate available therapies. 2. Histologically confirmed diagnosis of one of the following tumor types, along with clinical/pathologic

You may not be eligible for this study if the following are true:

  • 1. Subjects currently receiving other anticancer therapies, except that subjects with prostate cancer may continue to receive luteinizing hormone-releasing hormone (LHRH) analogue therapy. 2. More than 2 prior chemotherapy regimens for subjects in the


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.